Clearside Biomedical Inc.
CLSD
|
|
| |
|
| Trading Volume | 68 |
|
|
2.02 - 0.68 |
| Market Cap Full | $ 63M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.6% | 31.6% | -7.1% | -16.7% |
| Q2 | - | -18.2% | 7.7% | -35.8% |
| Q3 | - | -9.8% | -22.3% | -23.1% |
| Q4 | - | -12.9% | 34.5% | -0.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.6 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 6.8 | 12 | 10 | -16.2 | 10.9 | -10.5 | -12.5 | -9.8 | - | - | - | -11.2 |
| 2023 | |||||||||||
| 25.9 | -12.1 | -16.1 | -2.9 | 6.9 | 3.7 | 4.5 | -22.2 | -4.4 | -16.7 | 39.3 | 15.8 |
| 2022 | |||||||||||
| -29.1 | -18.2 | 43.6 | -33.2 | -12.5 | 9.8 | 3.3 | -12.4 | -15 | 0.9 | 6.1 | -7.4 |
| 2021 | |||||||||||
| 14.2 | 5.8 | -25.4 | 24.3 | -16.5 | 89.9 | 1 | 40 | -12.3 | -9.6 | -32.8 | -25.1 |
| 2020 | |||||||||||
| 21.6 | -46.5 | -15.4 | 16.5 | -6.1 | 1.1 | -12.8 | 4.9 | -11.6 | -11.2 | 48.9 | 36.3 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.1 | -0.1 | -0.1 |
| Q2 | -0.2 | -0.1 | -0.1 | -0.1 |
| Q3 | -0.2 | -0.1 | -0.1 | -0.1 |
| Q4 | 0 | -0.2 | 0.3 | -0.1 |
| A | -0.45 | -0.6 | 0 | -0.4 |